Renal diseases in childhood form a spectrum of different conditions with potential long-term consequences. Given that, a great effort has been made by researchers to identify candidate biomarkers that are able to influence diagnosis and prognosis, in particular by using omics techniques (e.g., metabolomics, lipidomics, genomics, and transcriptomics). Over the past decades, metabolomics has added a promising number of ‘new’ biomarkers to the ‘old’ group through better physiopathological knowledge, paving the way for insightful perspectives on the management of different renal diseases. We aimed to summarize the most recent omics evidence in the main renal pediatric diseases (including acute renal injury, kidney transplantation, chronic kidne...
Background: Clinical metabolomics is a recent "omic" technology which is defined as a global holisti...
Chronic kidney disease (CKD) patients are characterized by a high residual risk for cardiovascular (...
Kidney diseases still pose one of the biggest challenges for global health, and their heterogeneity ...
Renal diseases in childhood form a spectrum of different conditions with potential long-term consequ...
Metabolomics, the latest of the "omics" sciences, has a non-selective approach and can thus lead to ...
Diseases of the kidney are difficult to diagnose and treat. This review summarises the definition, c...
Introduction: Metabolomics offers considerable promise in early disease detection. We set out to tes...
Diseases of the kidney are difficult to diagnose and treat. This review summarises the definition, c...
Omics refers to the collective technologies used to explore the roles and relationships of the vario...
Omics refers to the collective technologies used to explore the roles and relationships of the vario...
Renal dysplasia is a severe congenital abnormality of the kidney parenchyma, which is an important c...
Identification of novel drug-induced toxic nephropathy and acute kidney injury (AKI) biomarkers has ...
Abstract Pediatric urolithiasis is a common urologic disease with high morbidity and recurrence rate...
Identification of novel drug-induced toxic nephropathy and acute kidney injury (AKI) biomarkers has ...
International audienceRecent progress in proteomic analysis and strategies for the identification of...
Background: Clinical metabolomics is a recent "omic" technology which is defined as a global holisti...
Chronic kidney disease (CKD) patients are characterized by a high residual risk for cardiovascular (...
Kidney diseases still pose one of the biggest challenges for global health, and their heterogeneity ...
Renal diseases in childhood form a spectrum of different conditions with potential long-term consequ...
Metabolomics, the latest of the "omics" sciences, has a non-selective approach and can thus lead to ...
Diseases of the kidney are difficult to diagnose and treat. This review summarises the definition, c...
Introduction: Metabolomics offers considerable promise in early disease detection. We set out to tes...
Diseases of the kidney are difficult to diagnose and treat. This review summarises the definition, c...
Omics refers to the collective technologies used to explore the roles and relationships of the vario...
Omics refers to the collective technologies used to explore the roles and relationships of the vario...
Renal dysplasia is a severe congenital abnormality of the kidney parenchyma, which is an important c...
Identification of novel drug-induced toxic nephropathy and acute kidney injury (AKI) biomarkers has ...
Abstract Pediatric urolithiasis is a common urologic disease with high morbidity and recurrence rate...
Identification of novel drug-induced toxic nephropathy and acute kidney injury (AKI) biomarkers has ...
International audienceRecent progress in proteomic analysis and strategies for the identification of...
Background: Clinical metabolomics is a recent "omic" technology which is defined as a global holisti...
Chronic kidney disease (CKD) patients are characterized by a high residual risk for cardiovascular (...
Kidney diseases still pose one of the biggest challenges for global health, and their heterogeneity ...